Key Highlights

  • NewGenIvf Group Limited (NASDAQ:NIVF) fell 13.01% to about USD 1.27 in early trading on Monday, October 26, 2026, days after a second reverse split took effect.
  • A 1-for-4 consolidation took effect on Monday, October 12, 2026, cutting Class A ordinary shares from about 35.7 million to about 8.9 million on the company's figures.
  • A further 1-for-8 consolidation was scheduled for Friday, October 23, 2026, which would make a combined ratio of 1-for-32 within about two weeks.
  • The company has not issued a release explaining the Monday decline, so the move is best read as post-split trading in a very small float.

The Move After Two Consolidations

NewGenIvf Group Limited (NASDAQ:NIVF) traded about 13.01% lower at roughly USD 1.27 per share in early trading on Monday, October 26, 2026, with prices intraday. The company has not issued a release explaining the move. Its most recent corporate actions were share consolidations. A regulatory filing dated Wednesday, October 7, 2026 set a 1-for-4 reverse split of Class A ordinary shares effective at 12:01 a.m. ET on Monday, October 12, 2026, under a new CUSIP, which is the security identifier. The company retained the NIVF symbol. The board approved the split on Wednesday, September 16, 2026, and no shareholder vote was required. A second ratio of 1-for-8 was scheduled for Friday, October 23, 2026, according to exchange notices.

How a Reverse Split Reshapes the Share Count

A reverse split combines several shares into one, which lifts the quoted price without changing the value of a holding. On the company's own figures, the 1-for-4 step reduced Class A shares from about 35,688,329 to about 8,922,083 as of Tuesday, October 6, 2026, although convertible note exercises could raise the count. A further 1-for-8 step would, by simple arithmetic, leave roughly 1.1 million shares before new issuance. Such a small count means thin liquidity, where a few orders move the price by double digits. Companies in this position often use splits to restore compliance with the exchange's minimum bid price, which is USD 1.00 per share, and convertible notes can then add shares quickly. Options, warrants and convertibles were adjusted by dividing by four in the first step.

Risks and What to Watch

The principal risk is dilution. Convertible notes allow the lender to exchange debt for new shares, and each conversion enlarges a very small share base, which can pressure the price even after a split. A second risk is liquidity: with a float near one million shares on the arithmetic above, wide spreads and sharp reversals are common. A third risk is that a price lifted by consolidation can drift back toward the compliance threshold if the business does not grow. NewGenIvf (NASDAQ:NIVF) offers fertility and assisted reproduction services in Asia, a sector that depends on patient volumes. Investors should watch for further regulatory filings, any exchange compliance letters and the fiscal results due in the coming months, with the Federal Reserve decision on Wednesday, October 28, 2026 setting the funding backdrop.

Where Things Stand

The answer is that NewGenIvf Group Limited (NASDAQ:NIVF) fell 13.01% as a thinly traded stock after two reverse splits, with no company-specific news explaining the decline. The cumulative 1-for-32 ratio, calculated from the 1-for-4 and 1-for-8 steps, left a very small share count and high sensitivity to note conversions. The next catalysts are any filing on convertible note conversions, an exchange notice on the minimum bid price and the Federal Reserve decision on Wednesday, October 28, 2026. Reverse splits do not change business value, small caps can move sharply in either direction, and this is not investment advice.